Elestrin

Atrophic Vaginitis, Low Testosterone, Hypogonadism + 27 more

Treatment

5 FDA approvals

20 Active Studies for Elestrin

What is Elestrin

Estradiol

The Generic name of this drug

Treatment Summary

Estradiol is a hormone naturally produced by females. It is available in several forms, including tablets, injections, vaginal rings, patches, sprays, gels, and creams. When taken orally or by injection, estradiol is usually combined with a pro-drug ester. Ethinyl estradiol (EE) is a synthetic form of estradiol that is used in most combination oral contraceptive pills. EE is more potent and has a higher bioavailability than estradiol, making it better suited for oral administration.

Estraderm

is the brand name

image of different drug pills on a surface

Elestrin Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Estraderm

Estradiol

1986

373

Approved as Treatment by the FDA

Estradiol, also known as Estraderm, is approved by the FDA for 5 uses like Hormonal Contraception and Breast Cancer .

Hormonal Contraception

Used to treat Hormonal Contraception therapy in combination with Levonorgestrel

Breast Cancer

Birth Control

Used to treat Contraception in combination with Levonorgestrel

Palliative Treatment

Breast Cancer

Effectiveness

How Elestrin Affects Patients

Estradiol is used to help reduce symptoms such as hot flashes and vaginal dryness. It can also increase bone density and improve your lipids (fats in your blood). Estradiol increases the production of sex hormone binding globulin (SHBG) and thyroid-binding globulin (TBG), and decreases follicle-stimulating hormone (FSH) in the pituitary gland. However, long-term use of estradiol may be linked to an increased risk of cardiovascular disease, deep vein thrombosis (DVT) and stroke, so should be avoided in those at high

How Elestrin works in the body

Estrogen is a hormone found in many tissues of the body, including the breast, uterus, ovaries, skin, prostate, bones, fat, and brain. In adult women, the ovaries produce most of the estrogen in the body. After menopause, though, the adrenal glands are the main source of estrogen. Estrogen has two main types: estradiol, which is stronger and more potent, and estrone. Estrogen works by binding to receptors in the body called estrogen receptors (ERα and ERβ). This causes a reaction in the cells that produces proteins which give estrogen its effects. In postmen

When to interrupt dosage

The dosage of Elestrin is contingent upon the diagnosed condition, including Premature Menopause, Pharmaceutical Preparations and Postmenopause. The magnitude of dosage is contingent upon the listed method of administration in the subsequent table.

Condition

Dosage

Administration

Hot Flashes

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Balanitis Xerotica Obliterans

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Hot flashes

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Palliative Treatment

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Breast

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Amenorrhea

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Therapeutic procedure

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Postmenopause

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Breast Cancer

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Vasomotor System

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Prostate Cancer

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Pharmaceutical Preparations

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Hormone Replacement Therapy

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

female castration

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

estradiol

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Premature Menopause

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Atrophic

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Hypogonadism

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Osteoporosis

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

hypoestrogenism

0.00052 mg/mg, , 0.005 mg/hour, 0.5 mg, 1.0 mg, 0.00025 mg/mg, 0.0005 mg/mg, 0.001 mg/mg, 2.0 mg, 0.0025 mg/hour, 0.0075 mg/hour, 0.01 mg/hour, 0.00375 mg/hour, 0.006 mg/hour, 1.53 mg, 0.0006 mg/mg, 10.0 mg/mL, 40.0 mg/mL, 20.0 mg/mL, 0.0014 mg/hour, 5.0 mg/mL, 0.097 mg/[USP'U], 0.146 mg/[USP'U], 0.194 mg/[USP'U], 4.4 mg, 0.01 mg/[USP'U], 0.01 mg, 10.0 mg, 12.5 mg, 15.0 mg, 18.0 mg, 20.0 mg, 22.0 mg, 25.0 mg, 6.0 mg, 5.0 mg, 0.06 %, 4.0 mg, 8.0 mg, 0.1 %, 3.28 mg, 4.33 mg, 8.66 mg, 6.56 mg, 0.025 mg, 0.00075 mg/mg, 0.51 mg, 0.62 mg, 0.0001 mg/mg, 0.0045 mg/hour, 0.0052 mg/mg, 1.5 mg, 1.8 mg, 2.5 mg/mL, 0.45 mg, 0.9 mg, 0.05 mg, 0.004 mg, 0.0025 mg/mg, 2.17 mg, 6.57 mg, 4.84 mg, 4.95 mg, 14.0 mg, 0.005 mg/mg, 0.0075 mg/mg, 50.0 mg, 0.00125 mg/mg, 0.00005 mg/mg

Topical, Gel, metered, , Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Ring - Vaginal, Vaginal, Ring, Spray - Transdermal, Transdermal, Spray, Patch, extended release, Patch, extended release - Transdermal, Gel - Transdermal, Injection - Intramuscular, Intramuscular, Patch, Patch - Transdermal, Spray, metered - Transdermal, Tablet, film coated - Vaginal, Spray, metered, Film, extended release, Film, extended release - Transdermal, Pellet, Pellet - Oral, Tablet - Vaginal, Gel, metered - Transdermal, Oral; Transdermal, Insert - Vaginal, Insert, Cream - Vaginal, Cream, Gel, metered - Topical, Injection, solution - Intramuscular, Lotion - Topical, Emulsion - Topical, Emulsion, Capsule, Capsule - Oral, Capsule; Spray, metered, Capsule; Spray, metered - Oral; Transdermal, Cream - Transdermal, Pellet, implantable - Subcutaneous, Pellet, implantable

Warnings

Elestrin Contraindications

Condition

Risk Level

Notes

Breast

Do Not Combine

Angioedema

Do Not Combine

Venous Thrombosis

Do Not Combine

undiagnosed abnormal genital bleeding

Do Not Combine

estrogen-dependent neoplasia

Do Not Combine

Liver Dysfunction

Do Not Combine

Breast

Do Not Combine

suspected pregnancy

Do Not Combine

Breast Cancer

Do Not Combine

Pulmonary Embolism

Do Not Combine

Angioedema

Do Not Combine

Deep Vein Thrombosis

Do Not Combine

Thromboembolism

Do Not Combine

Neoplasms, Hormone-Dependent

Do Not Combine

Pulmonary Embolism

Do Not Combine

Thromboembolism

Do Not Combine

Thrombophilia

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Estradiol may interact with Pulse Frequency

There are 20 known major drug interactions with Elestrin.

Common Elestrin Drug Interactions

Drug Name

Risk Level

Description

Aminophylline

Major

The metabolism of Aminophylline can be decreased when combined with Estradiol.

Anagrelide

Major

The metabolism of Anagrelide can be decreased when combined with Estradiol.

Anastrozole

Major

The therapeutic efficacy of Anastrozole can be decreased when used in combination with Estradiol.

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Estradiol.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Estradiol.

Elestrin Toxicity & Overdose Risk

Tests in rats have shown that estradiol can be toxic in doses of 0.003 mg/kg per day or higher. The toxic dose for women is 21 mg/kg per day, and for rats it is 960 mg/kg. An overdose of estradiol can lead to nausea, vomiting, abdominal pain, breast tenderness, blood clots, and vaginal bleeding. If a person has overdosed on estradiol, it is best to stop taking the drug and seek supportive care.

image of a doctor in a lab doing drug, clinical research

Elestrin Novel Uses: Which Conditions Have a Clinical Trial Featuring Elestrin?

867 active studies are investigating the potential of Elestrin to provide treatment for Osteoporosis, an absence of menstruation in the preceding 6 months and Urogenital Atrophy.

Condition

Clinical Trials

Trial Phases

Hysterectomy

6 Actively Recruiting

Phase 4, Phase 3, Not Applicable

Breast Cancer

19 Actively Recruiting

Phase 2, Not Applicable

estradiol

0 Actively Recruiting

Birth Control

20 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Early Phase 1, Phase 2

Postmenopause

5 Actively Recruiting

Not Applicable

Metastatic Breast Cancer

0 Actively Recruiting

Osteoporosis, Postmenopausal

0 Actively Recruiting

Therapeutic procedure

0 Actively Recruiting

moderate to severe symptoms

0 Actively Recruiting

Balanitis Xerotica Obliterans

0 Actively Recruiting

Amenorrhea

1 Actively Recruiting

Phase 2

Osteoporosis

26 Actively Recruiting

Not Applicable, Phase 4, Phase 1, Phase 3, Phase 2

Prostate Cancer

72 Actively Recruiting

Not Applicable, Phase 3, Phase 2, Phase 1, Early Phase 1

Breast

0 Actively Recruiting

Urogenital atrophy

0 Actively Recruiting

Low Testosterone

4 Actively Recruiting

Phase 2, Phase 1, Phase 4

Vasomotor System

0 Actively Recruiting

Atrophic Vaginitis

1 Actively Recruiting

Not Applicable

Hot flashes

19 Actively Recruiting

Not Applicable, Phase 2, Phase 4, Early Phase 1, Phase 3, Phase 1

Hormone Replacement Therapy

0 Actively Recruiting

Elestrin Reviews: What are patients saying about Elestrin?

5

Patient Review

6/9/2013

Elestrin for Low Estrogen After Operation to Remove Ovaries

Elestrin is a fantastic product that is really easy to use. You'll need to give it some time to work properly, but it's definitely worth it! I'm so glad I found this product - it's given me my life back!

5

Patient Review

3/13/2013

Elestrin for "Change of Life" Signs

My doctor prescribed this and it has helped me so much, especially because I wanted something that was bio-identical.

4.7

Patient Review

7/8/2010

Elestrin for Low Estrogen After Operation to Remove Ovaries

Elestrin gel has been a godsend. I use it twice daily as directed, and have seen significant improvements in my quality of life. No more hot flashes or mood swings!

4.7

Patient Review

2/4/2011

Elestrin for Low Estrogen After Operation to Remove Ovaries

Since starting this medication, I have seen a significant reduction in hot flashes and headaches. Additionally, my mood swings have improved. This has been an overall effective treatment for me.

4.7

Patient Review

5/6/2014

Elestrin for "Change of Life" Signs

Elestrin has helped me feel like myself again. I very rarely have hot flashes and my emotions are more stable.

4.7

Patient Review

11/3/2010

Elestrin for "Change of Life" Signs

I've been using this for a little over two weeks now, and it's helped me quite a bit. The patch was uncomfortable and difficult to keep on for an entire year.

4.3

Patient Review

2/28/2010

Elestrin for Low Estrogen After Operation to Remove Ovaries

The only problem I've had is that the skin on my arms has gotten darker where I apply the gel.

4

Patient Review

9/26/2013

Elestrin for Low Estrogen After Operation to Remove Ovaries

I haven't had any bad side effects, but I am curious about how long I will have to take this medication. I'm currently 57 years old. Does anyone have a similar experience or opinion on this?

3.7

Patient Review

7/23/2011

Elestrin for Low Estrogen After Operation to Remove Ovaries

I'm losing hair, which is a major bummer. I might have to stop taking this medication as a result.

2.3

Patient Review

7/8/2010

Elestrin for Low Estrogen After Operation to Remove Ovaries

I had my ovaries removed via laparoscopic surgery six days ago, and I'm still feeling pretty out of sorts. The past few days my mood has been all over the place, and I'm hoping that each day will bring more balance. This treatment seems to help a little bit, but I'm still not back to normal yet.

2

Patient Review

8/4/2012

Elestrin for Low Estrogen After Operation to Remove Ovaries

I found that this treatment made me very confused, and on the second day my brain felt numb. By the third day, I had blurred vision. I decided to stick with Premarin because I didn't like the weight gain associated with this medication.

1.7

Patient Review

8/20/2011

Elestrin for Primary Ovarian Failure

After using Elestrin for only a week as directed, I started experiencing hair loss, general malaise, and skin rashes. Needless to say, I stopped this treatment immediately.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about elestrin

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a generic for Elestrin gel?

"There is no cheaper generic version of Elestrin currently available. The most common version of Elestrin is covered by 83% of insurance plans, with a co-pay of $60.00-$77.50. However, some pharmacies may offer lower prices without insurance."

Answered by AI

How much does Elestrin cost?

"The cheapest price for Elestrin is $237.74. This is 16% lower than the average retail price of $283.62."

Answered by AI

What is Elestrin gel?

"Elestrin is a prescription medication used to manage the symptoms of night sweats, hot flashes, and flushes that are often associated with menopause. It may be used alone or in conjunction with other medications. Elestrin belongs to a class of drugs called estrogen derivatives. Its safety and efficacy in children has not been established."

Answered by AI

What is Elestrin used for?

"This medication contains the female hormone estrogen. You absorb it through your skin and into your bloodstream. Doctors prescribe it to help reduce hot flashes, a symptom of menopause. Some brands of this medication can also help relieve vaginal symptoms of menopause, such asdryness, burning, and itching."

Answered by AI

Clinical Trials for Elestrin

Image of University Health Network - Princess Margaret Cancer Center in Toronto, Canada.

Tamoxifen for Testosterone Recovery in Prostate Cancer

18+
Male
Toronto, Canada

Androgen deprivation therapy (ADT) is a cornerstone therapy in the treatment of curable prostate cancer (PCa). However, ADT often leads to a protracted testosterone recovery period in most men or absence of complete recovery in 10-25% of cases. The hypogonadal state has significant psychosocial and physical side effects. Therefore, limiting ADT effect's duration beyond the prescribed castration period is very compelling to patients and providers alike. Tamoxifen, a well-established selective estrogen receptor modulator, offers a novel and cost-effective approach to accelerate testosterone recovery in men with secondary hypogonadism. This project addresses a critical gap in global cancer care by evaluating Tamoxifen as a viable solution for reducing the burden of delayed testosterone recovery and its associated side effects, particularly in resource-limited settings.

Phase 2
Waitlist Available

University Health Network - Princess Margaret Cancer Center

Image of Albert Einstein College of Medicine in The Bronx, United States.

Vaginal Estradiol vs Moisturizer for Menopause in Women with HIV

40 - 70
Female
The Bronx, NY

This is a research study about the effects of vaginal estradiol compared to moisturizer on vaginal symptoms of menopause and the microbiome in women with HIV. This research study aims to understand how vaginal products affect the aging of the female genital tract in women living with HIV who are menopausal or perimenopausal and have vaginal or urinary symptoms. There is a comparison group of women who are living without HIV. Participants with HIV and vaginal or urinary menopausal symptoms (e.g., dryness, irritation, soreness, itching, pain with sex, dysuria, urgency, or frequent urinary tract infections) will be asked to apply vaginal estradiol or a vaginal moisturizer (Replens). Participants who have vaginal or urinary menopausal symptoms and do not have HIV will receive vaginal estradiol.

Phase 4
Waitlist Available

Albert Einstein College of Medicine

Kerry J Murphy, MD

Have you considered Elestrin clinical trials?

We made a collection of clinical trials featuring Elestrin, we think they might fit your search criteria.
Go to Trials
Image of Resound Research for Reproductive Health, a project of the Tides Center in San Francisco, United States.

"Vasectomy: Right for Me?" Decision Aid for Birth Control

21 - 55
Male
San Francisco, CA

The goal of this trial is to learn if a web-based decision aid designed to provide evidence-based information about vasectomy and other birth control options helps improve users' decision-making about birth control. The main questions it aims to answer are: * Do people who use the decision aid have better knowledge about vasectomy? * Do people who use the decision aid have lower conflict with their decision? Participants will: * Use the decision aid (if they are assigned to the intervention arm). * Answer survey questions about their knowledge, decision-making, interest in vasectomy, and healthcare navigation experiences.

Waitlist Available
Has No Placebo

Resound Research for Reproductive Health, a project of the Tides Center (+1 Sites)

Sonya Borrero, MD, MS

Image of University of Texas in Houston, United States.

vNOTES Hysterectomy for Pelvic Prolapse

18+
Female
Houston, TX

As the adoption of Vaginal natural orifice transluminal endoscopic surgery (vNOTES) expands, attention is shifting from feasibility studies to the refinement of surgical steps that optimize long-term pelvic health. One technical distinction between vNOTES hysterectomy and conventional laparoscopic or robotic hysterectomy is the routine early transection of the uterosacral ligaments as the approach is caudal-cephalic. These ligaments are not merely anatomic landmarks-they are the primary apical support structures of the vagina, anchoring the vaginal cuff to the sacrum and providing resistance against downward displacement. Disruption of this support can predispose patients to apical vaginal prolapse, a condition that significantly affects quality of life and may require complex reconstructive surgery. Uterosacral ligament suspension (USLS) is a well-established, effective method of restoring apical support at the time of hysterectomy. Incorporating uterosacral suspension into vNOTES hysterectomy is a logical evolution toward ensuring that minimally invasive innovation does not come at the expense of long-term pelvic health. By adapting and standardizing this reconstructive step for vNOTES, surgeons can maintain apical support, reduce future prolapse risk, and uphold the same quality benchmarks established in laparoscopic and vaginal surgery. OBJECTIVE AND HYPOTHESIS: This study aims to present a practical, reproducible technique for performing USLS in the vNOTES setting and to evaluate its potential immediate benefits, possible complication rates, and additional operative time compared with vNOTES hysterectomy without USLS. In doing so, we seek to demonstrate that preventive pelvic support can be seamlessly integrated without compromising the efficiency or advantages of the transvaginal endoscopic approach.

Waitlist Available
Paid Trial

University of Texas

Have you considered Elestrin clinical trials?

We made a collection of clinical trials featuring Elestrin, we think they might fit your search criteria.
Go to Trials
Image of M D Anderson Cancer Center in Houston, United States.

Decision Support Tool for Prostate Cancer

18+
Male
Houston, TX

This clinical trial identifies factors associated with completing genetic testing, aids in the development of a decision support tool, and tests how well the decision support tool works to enhance germline genetic testing in patients with prostate cancer. Germline genetic testing is a guideline-recommended standard of care for many patients with prostate cancer. Completing genetic testing can enable the use of targeted therapies, offers access to novel clinical trials, provides valuable information, and can help identify at risk family members. The decision support tool may educate patients and assist in the decision to engage with germline genetic testing.

Waitlist Available
Has No Placebo

M D Anderson Cancer Center

Debanjan Pain

Image of VA Greater Los Angeles Healthcare System, West Los Angeles, CA in West Los Angeles, United States.

EBQI Strategies for Women's Health

Any Age
All Sexes
West Los Angeles, CA

Women Veterans are the fastest growing segment of VA users, with most users in midlife. This dramatic growth has created challenges for VA to ensure that appropriate services are available to meet women Veterans' needs, and that they will want and be able to use those services. Furthermore, few VA improvement efforts have focused on women Veterans' health and health care in midlife. The EMPOWER QUERI 3.0 Program is a cluster randomized type 3 hybrid implementation-effectiveness trial testing two strategies designed to support implementation and sustainment of evidence-based practices for women Veterans in at least 18 VA facilities from 4 regions.

Waitlist Available
Has No Placebo

VA Greater Los Angeles Healthcare System, West Los Angeles, CA

Erin P Finley, PhD MPH

Have you considered Elestrin clinical trials?

We made a collection of clinical trials featuring Elestrin, we think they might fit your search criteria.
Go to Trials